There is mounting evidence that statin use is beneficial for COVID-19 outcomes. We
performed a systematic review and meta-analysis to evaluate the association between statin …

Scientists are concerned about the origins of SARS-CoV-2, which has caused a devastating
global pandemic. In a letter recently published in Science, 18 investigators called for more …

Background There is little evidence on the relationship between statin use and the risk of
hospitalization attributable to COVID‐19. Methods and Results The French National …

Abstract Background Coronavirus disease-2019 (COVID-19) is characterized by a
dysfunctional immune response and abnormal blood rheology that contribute to endothelial …

Abstract Coronavirus disease 2019 (COVID-19) is characterized by striking dysregulation of
the immune system, with evidence of hyperinflammation, an impaired induction of …

Myopathy is the most common side effect of statins, but it has not been addressed effectively.
In anticipation of its wider use as a small molecule to complement the current COVID-19 …

Abstract Background Coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to multiorgan insufficiency and …

The Coronavirus Disease 2019 (COVID-19) showed worse prognosis and higher mortality in
individuals with obesity. Dyslipidemia is a major link between obesity and COVID-19 …

disease-2019(COVID-19) is caused by the severe acute respiratory syndrome-coronavirus-2
(SARS-CoV-2) and is associated with pathologic inflammation and thrombosis. Most COVID …

In low-and middle-income countries (LMICs), inexpensive generic drugs like statins, ACE
inhibitors, and ARBs, especially if used in combination, might be the only practical way to …